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doi:10.1Objective: To investigate effects of epinephrine and levosimendan on cardiac function after rewarming from
deep hypothermia.
Methods: Forty-five maleWistar rats (400-500 g) underwent cardiopulmonary bypass and were cooled to a core
temperature of 13C to 15C within 30 minutes. After 15 minutes of deep hypothermic circulatory arrest, they
were randomly assigned to treatment with levosimendan (12 mg/kg; infusion of 0.2 mg $ kg1 $min1) (n¼ 15) or
epinephrine (0.1 mg/kg; infusion of 0.1 mg $ kg1 $min1) (n¼ 15) or saline as control (n¼ 10). The rewarming
lasted 60 minutes. Systolic and diastolic function was evaluated at different preloads with a conductance
catheter, including the slope of the end-systolic pressure–volume relation (ESPVR) and end-diastolic pres-
sure–volume relationship (EDPVR), preload recruitable stroke work, first derivative of left ventricular pressure
(þdP/dt), and its relation to end-diastolic volume, as well as the time constant of left ventricular relaxation (Tau)
and maximal slope of the diastolic pressure decrement (dP/dt). Plasma lactate levels were collected.
Results: Stroke volume, ejection fraction andþdP/dt were significantly higher in the levosimendan-treated
group than in the epinephrine group. The slope values of preload recruitable stroke work, ESPVR, and the
relation ofþdP/dt to end-diastolic volume were significantly higher, indicating a better contractility and in-
creased systolic function.dP/dt was significantly higher in the levosimendan group (3468  320 vs 1103 
101 mm Hg/s; P<.01). Left ventricular stiffness expressed by EDPVR and relaxation (Tau) were significantly
improved in levosimendan-treated group. Plasma lactated concentrations were lower in levosimendan group
(2.03  1.27 vs 4.64  1.02; P<.05).
Conclusions: Levosimendan has better inotropic and lusitropic effects than epinephrine during rewarming from
deep hypothermic circulatory arrest with cardiopulmonary bypass. (J Thorac Cardiovasc Surg 2012;143:209-14)Deep hypothermic circulatory arrest (DHCA) is widely
used during repair of the aortic arch and congenital heart de-
fects as a method of cerebral protection. Since the 1980s,
when DHCA becamewidely used, surgical outcome has im-
proved along with survival and cardiac morbidity.1 Never-
theless, the effect of myocardial ischemia–reperfusion
injury combined with hypothermia–rewarming has impor-
tant clinical implications and remains a significant contrib-
utor to perioperative morbidity and mortality.2
Similar to the cardiac surgical setting, hypotension and
low cardiac output are common after rewarming from acci-
dental hypothermia, and up to 50% to 80% of patients havee Department of Surgery, Division of Cardiac Surgery, University of Verona,
a, Italy.
ures: Authors have nothing to disclose with regard to commercial support.
the 91st Annual Meeting of The American Association for Thoracic Sur-
Philadelphia, Pennsylvania, May 7-11, 2011.
d for publication May 10, 2011; revisions received Aug 18, 2011; accepted
blication Sept 15, 2011; available ahead of print Oct 19, 2011.
for reprints: Alessio Rungatscher, MD, PhD, Department of Surgery,
ersity of Verona, Piazzale Stefani 1, 37126 Verona, Italy (E-mail: alessio.
tscher@univr.it).
23/$36.00
ht  2012 by The American Association for Thoracic Surgery
016/j.jtcvs.2011.09.020
The Journal of Thoracic and Cahemodynamic instability.3 Underlying this process, there is
an overall myocardial depression, including both systolic
and diastolic dysfunction, that may require the use of inotro-
pic drugs.4
Clinical guidelines for management of myocardial
dysfunction, either in the setting of cardiac surgical inter-
ventions or in accidental hypothermia, are still undeter-
mined. Epinephrine is currently used in the treatment of
hypothermia-induced cardiac dysfunction.5 However, the
evidence of efficacy of epinephrine in this setting has
been questioned.4,6,7
This study was designed to investigate whether levosi-
mendan, a Ca2þ sensitizer, may be effective in improving
myocardial dysfunction after rewarming from DHCA and
to compare its efficacy with that of epinephrine.E
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Rat Cardiopulmonary Bypass (CPB) Model
After institutional animal care committee approval, 45 male Wistar rats
(400-450 g; Harlan, Udine, Italy) housed under standard laboratory condi-
tions were anesthetized (sodium penthobarbital, 30 mg/kg intraperitonally)
and intubated through the oropharynx with a 14-gauge polyethylene tube.
They were mechanically ventilated with a rodent respirator (Harvard
Apparatus Inc, Holliston, Mass). The tidal volume was 7 mL/kg and therdiovascular Surgery c Volume 143, Number 1 209
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
DHCA ¼ deep hypothermic circulatory arrest
dP/dt ¼ maximal slope of the systolic pressure
increment
dP/
dtMAX
¼ systolic pressure increment
dP/dtMIN ¼ diastolic pressure decrement
EDPVR ¼ end-diastolic pressure–volume
relationship
ESPVR ¼ end-systolic pressure–volume
relationship
EDV ¼ end-diastolic volume
LV ¼ left ventricular
MAP ¼ mean arterial pressure
P-V ¼ pressure–volume
SV ¼ stroke volume
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spired oxygen fraction ¼ 0.5). Ventilation was adjusted to keep an arterial
carbon dioxide tension of 35 to 45 mm Hg. Rats were secured supine on
a heating board to maintain rectal temperature at 37C during the surgical
procedure before the initiation of CPB. A thermocouple microprobe was
inserted into the left femoral artery and advanced into the descending aorta
for the measurement of blood temperature. The left femoral artery was can-
nulated with a heparinized 24-gauge Teflon catheter to monitor systemic
arterial pressure and to collect arterial blood for gas analysis. Central can-
nulation was performed as previously described.8 In brief, after complete
sternotomy, a venous cannula (a modified 4-hole 16-gauge Angiocath cath-
eter) was advanced into the right atrium using a right trans–superior vena
cava approach, allowing excellent drainage. The left common carotid ar-
tery was cannulated using an 18-gauge catheter advanced to the aortic
arch and connected to the arterial perfusion line for the CPB circuit. Full
heparinization (500 IU/kg) was assured after surgical preparation and im-
mediately before CPB initiation to reduce overall blood loss.
CPB was set up as previously described.8 The setup consisted of a ve-
nous reservoir, a roller pump, a hollow-fiber oxygenator (Sorin, Mirandola,
Italy), and a vacuum regulator with an applied pressure of30 mm H2O to
facilitate venous drainage, all connected by 1.6-mm internal diameter plas-
tic tubing. Total priming volume was 10.5 mL, gas exchange surface was
450 cm2, and heat exchange surface was 15.8 cm2.
Study Design
CPB was instituted at a flow rate of 120 mL $ kg1 $min1. A core tem-
perature of 15C to 13Cwas achieved over 30 minutes using CPB-assisted
cooling. The roller pump was turned off and DHCA, as confirmed by asys-
tole and lack of measurable mean arterial pressure, was maintained for 15
minutes at 13C to 15C.
With the reinstitution of CPB, rewarming started at a flow rate of 100
mL $ kg1 $ min1. At the beginning of rewarming, rats were randomly as-
signed to treatment with levosimendan (loading dose of 12 mg/kg, infusion
of 0.2 mg $ kg1 $min1) or epinephrine (loading dose of 0.1 mg/kg, infusion
of 0.1 mg $ kg1 $ min1) or saline as control.
Infusion started at 20C and was performed until CPB weaning.
CPB inflow rate was gradually increased, reaching the full rate of
120 mL $ kg1 $ min1 at the end of rewarming at 36C in a period of 60
minutes. Rewarming was assisted by a heating blanket and a heating
lamp. The temperature gradient between the CPB circuit and body core210 The Journal of Thoracic and Cardiovascular Surgdid not exceed 10C. After full rewarming, the remaining priming volume
was reinfused and animals were weaned from CPB. After the experiment,
animals were humanely killed by anesthetic overdose.
Measurements
Hemodynamic parameters were collected continuously during the ex-
periments with a 2F Mikro-Tip pressure–volume (P-V) conductance cath-
eter (SPR-838; Millar Instruments, Inc, Houston, Tex) inserted into the
right carotid artery and advanced into the left ventricle. Signals were con-
tinuously recorded at a sampling rate of 1000 samples/s using a P-V con-
ductance system (MPVS-400; Millar Instruments), stored, and displayed
on a personal computer by the PowerLab Chart5 Software System (AD In-
struments, Colorado Springs, Colo). With the use of a special P-Vanalysis
program (PVAN; Millar Instruments), heart rate, mean arterial pressure
(MAP), maximal slope of the systolic pressure increment (dP/dt) and the
diastolic pressure decrement (dP/dtMIN), and time constant of left ventricular
(LV) pressure decay (Tau, according to the Weiss method) were computed
and calculated. Stroke volume (SV) and cardiac output were calculated and
corrected according to in vitro and in vivo volume calibrations using PVAN
software.9
In addition to the above parameters, LV P-V relations were measured by
transiently occluding the inferior vena cava (reducing preload) under the
diaphragm by tying a snare suture around the vein at baseline condition
and after CPB weaning. The slope of the LVend-systolic P-V relationship
(ESPVR), preload recruitable stroke work, and the dP/dt-EDV relation
were calculated as load-independent indexes of LV contractility. The slope
of the LV end-diastolic P-V relationship (EDPVR) was calculated as reli-
able index of LV stiffness.9
Lactate levels were measured on arterial blood samples collected after
the end of CPB-assisted rewarming.
Statistical Analysis
Results are presented as means  standard error. For between-group
comparisons, 1-way analysis of variancewas used, followed by an unpaired
2-tailed Student t test or paired t test to evaluate differences between groups
and within groups versus the baseline, respectively.RESULTS
Forty-five rats were used in this study and randomized
into 3 groups. In the control group, 3 animals had ventricu-
lar fibrillation during rewarming and 2 had an MAP less
than 40 mm Hg after rewarming. In the epinephrine-
treated group, 2 rats had ventricular fibrillation during
rewarming. These animals were excluded from the data
analysis. In the levosimendan-treated groups, there were
no arrhythmic episodes and all 15 rats were successfully
rewarmed.
There were no differences in baseline hemodynamic pa-
rameters among the 3 groups (Figure 1). During hypother-
mia at 20C, it was possible to collect hemodynamic data
by temporarily turning off the roller pomp. Compared
with baseline normothermia, during deep hypothermia
there was a marked reduction (60%-95%) in most hemody-
namic parameters (Figure 1). However, SV was signifi-
cantly increased (30%) at 20C. Full cardiac arrest was
achieved at 14C in all animals.
After rewarming, MAP was significantly increased
in epinephrine-treated rats compared with control and
up to 20% higher than the baseline values. In theery c January 2012
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FIGURE 1. Common clinical hemodynamic parameters at baseline normothermia, during hypothermia (recorded by temporarily turning off CPB at 20C),
and after rewarming. Values represent absolute changes (means  standard deviations). *P<.05; **P<.01. CPB, Cardiopulmonary bypass.
Rungatscher et al Evolving Technology/Basic Sciencelevosimendan-treated group, MAP was significantly higher
compared with control but up to 35% lower than baseline
values. Heart rate completely recovered after rewarming
and was similar to baseline in all 3 groups with a nonstatisti-
cally significant elevation in the epinephrine group.FIGURE 2. End-systolic pressure–volume (P-V) relationship (ESPVR) and end
P-V loops were obtained with a P-V conductance catheter system at different p
EDPVR between epinephrine- and levosimendan-treated rats. The increased slo
improved contractile function and diminished diastolic stiffness, respectively.
The Journal of Thoracic and CaAfter rewarming, SV was similar to baseline only in
levosimendan-treated rats and was significantly higher
compared with both the control and epinephrine-treated
groups. In the same way cardiac output was significantly
improved only in levosimendan-treated rats compared-diastolic P-V relationship (EDPVR). Original recordings of representative
reloads during vena cava occlusion and showed differences in ESPVR and
pe steepness of ESPVR and decreased of EDPVR in levosimendan indicate
rdiovascular Surgery c Volume 143, Number 1 211
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FIGURE 3. Maximal slope of the systolic pressure increment (dP/dtmax) and end-diastolic volume (EDV) relationship. The relation between dP/dtMAX and
EDVin 1 representative rat from the levosimendan- and epinephrine-treated groups is shown. Note that the slope values were higher in levosimendan-treated
than in epinephrine-treated rats, suggesting that systolic performance is improved after levosimendan infusion (A). Maximal slope of the systolic pressure
increment (dP/dtmax) at baseline normothermia and after hypothermia–rewarming is shown in the control group (black bar), epinephrinegroup (graybar), and
levosimendan group (white bar). *P<.05 versus control; P<.05 versus epinephrine (B). C and D, Preload recruitable stroke work (PRSW). The relation
between strokework and EDVin 1 representative rat from epinephrine and levosimendan group is shown. Note that slope values were higher in levosimendan
rats than in epinephrine rats, suggesting that systolic performance is augmented in levosimendan (C). PRSW is the slope value of the relationship between
strokework and end-diastolic volume (EDV) in the groups of control, levosimendan, and epinephrine. *P<.05 versus control; P<.05 versus epinephrine (D).
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ment without reaching significance.
Functional indices derived from P-V analysis at differ-
ent preloads are less influenced by loading conditions.
Figure 2 shows representative original P-V loops regis-
tered during transient occlusion of the inferior vena
cava after rewarming in epinephrine-treated and
levosimendan-treated rats. ESPVR was steeper after levo-
simendan infusion than after epinenephrine infusion, sug-
gesting a better systolic performance after levosimendan
infusion during rewarming. This was confirmed by dP/
dtMAX and dP/dtMAX related to EDV. dP/dtMAX is a classic
contractility parameter, but it is dependent on changes
in preload. Analysis of the relation ofdP/dtMAX to EDV al-
lowed a comparison of dP/dtMAX values of epinephrine-
treated and levosimendan-treated rats at a given EDV212 The Journal of Thoracic and Cardiovascular Surg(Figure 3). The slope of this relation was steeper in the
levosimendan-treated group. Another confirmation came
from preload recruitable stroke work (the slope of the lin-
ear elation between stroke work and EDV) (Figure 3).
The slope was steeper after levosimendan treatment com-
pared with epinephrine treatment, indicating an improved
systolic function determined by levosimendan in this set-
ting. Compared with the corresponding control animals,
the overall preload recruitable stroke work values were
significantly improved (Figure 3).
The diastolic function after rewarming was described by
LV relaxation index (dP/dtMIN and Tau) and stiffness index
(EDPVR) (Figure 4). Levosimendan significantly amelio-
rated LV relaxation compared with control. Epinephrine
only improved Tau compared with control although to
a lesser extent than levosimendan. The last improvementery c January 2012
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FIGURE 4. Indexes of left ventricular (LV) relaxation.Maximal slope of the
LV diastolic pressure decrement (dP/dtmin) and time constant of LV pressure
decay (Tau) at baseline normothermia and after hypothermia–rewarming in
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FIGURE 5. Lactate plasma levels after rewarming in the 3 groups.
P<.05 versus epinephrine.
Rungatscher et al Evolving Technology/Basic Scienceof EDPVR compared with epinephrine but the difference
was not statistically significant.
The lactate levels were significantly higher after treat-
ment with epinephrine and in the control group than after
levosimendan infusion (Figure 5).E
T
/B
SDISCUSSION
Whereas moderate hypothermia is a recognized method
of myocardial protection in cardiac surgery,10,11 deep
hypothermia, be it induced as a neuroprotective measure
during aortic arch interventions or be it accidental,
induces an overall myocardial depression owing to both
systolic and diastolic dysfunction.3 Although often tran-
sient, more permanent injury in the form of necrosis and ap-
optosis might occur. Pulmonary dysfunction, which is
frequently associated with hypothermia-induced myocar-
dial dysfunction, exacerbates the low cardiac output state.2
Experimental models of deep hypothermia and rewarm-
ing confirm and explain this clinical finding.10,12 In an
experimental animal model of DHCA, LV contractility,
relaxation, and afterload were markedly, but transiently,
depressed early after reperfusion and mildly depressed
late after reperfusion.13The Journal of Thoracic and CaThe determination of the pathophysiologic mechanisms
underlying cardiac dysfunction after hypothermia–rewarm-
ing attributes a pivotal role to Ca2þoverload and to the par-
adoxically reduced myofilament Ca2þ sensitivity.14 The
phosphorylation of troponin I represents a well-established
mechanism for decreased myofilament Ca2þ sensitivity.
The same phosphorylation could bemediated by phosphoki-
nase A activated by b-adrenergic stimulation.15
Moreover, cardiovascular effects mediated by b-adreno-
ceptors are significantly diminished after hypothermia, sug-
gesting that the use of b-adrenoceptor–specific agonist
should be reconsidered.16 Besides, pharmacologic therapy
with catecholamines presents substantial limitations be-
cause these are associated with elevated myocardial oxygen
consumption, arrhythmogenesis, and regional hypoperfu-
sion leading to organ damage.17,18
Levosimendan is a pyridazinone dinitrite derivative be-
longing to the new inotropic drugs class of Ca2þ sensitizer.
It presents a positive inotropic effect by sensitizing cardiac
troponin C to calcium during systole, thus increasing car-
diac performance without increasing myocardial oxygen
consumption and with a weak arrythmogenic effect.18
To the best of our knowledge, no data have been published
about the efficacy of levosimendan in improvingmyocardial
dysfunction after deep hypothermia–rewarming.
This study was conducted on a rat model of CPB previ-
ously validated and described.8 DHCA and CPB-assisted
rewarming reproduced the clinical setting of both cardiac
surgery interventions and extracorporeal resuscitation after
accidental hypothermia. The results of this study demon-
strated that levosimendan treatment during rewarming pro-
duced a significant improvement of clinical used parameters
of cardiac functions (heart rate, MAP, SV, and cardiac out-
put). In the same manner, more precise parameters derived
from P-V analysis and insensitive to preload effect con-
firmed significantly improved systolic function after levosi-
mendan treatment when compared with epinephrine.rdiovascular Surgery c Volume 143, Number 1 213
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provement in SVand an important elevation in lactate levels,
which were significant higher than levosimendan. More-
over, levosimendan was superior in improving diastolic
function, which was evident on LV relaxation indexes.
Further investigations are needed to validate these results
in the clinical setting and to evaluate the cost/benefit ratio in
high-risk patients. Nonetheless, on the basis of these find-
ings, use of Ca2þ sensitizer drugs, such as levosimendan,
seems rational in induced or accidental deep hypothermia.
The clinical experience with levosimendan is limited
to weaning from conventional CPB. Its superiority over cat-
echolamines was already demonstrated as postoperative
rescue therapy for high-risk patients difficult to wean
from CPB.18-20 The hemodynamic data were limited on
systolic function and were consistent with results of this
study. However, no data exist about effect of
levosimendan on diastolic function after CPB.
Finally, some important limitations remain. The animal
model does not faithfully reproduce the clinical setting. In
addition, inasmuch as only a single dose of epinephrine
and levosimendan with a particular treatment regimen (sin-
gle loading dose at the beginning of rewarming and then
continuous infusion from 20C to complete rewarming)
was investigated, one cannot rule out the possibility that dif-
ferent dosages or treatment schemes might have generated
different functional outcomes from the one herein. Never-
theless, this particular treatment regimen for ephinephrine
was deliberately chosen to compare results with prior
studies.4-6CONCLUSIONS
Levosimendan has better inotropic and lusitropic effects
than epinephrine during rewarming from experimental
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Dr Paul M. Kirshbom (Atlanta, Ga). No disclosures. I have
just a couple of quick questions. I could not tell from your presen-
tation whether the animals were off bypass when you did your he-
modynamic studies at the end or whether they were still on bypass.
Dr Rungatscher. They went through a complete cardiopulmo-
nary-assisted rewarming, until they reached 36C, then bypass was
weaned and they subsequently underwent hemodynamic analysis
by vena cava occlusion method.
Dr Kirshbom. So they were off bypass.
Just 1 quick question. Why do you think the lactate was in-
creased given the fact they were on bypass for the entire study
and they were off for a very brief period? Obviously, they were
on full bypass. Why would the lactate be increased for that very
brief period?
Dr Rungatscher. The arterial lactate levels were increased as
a result of 15 minutes of deep hypothermic circulatory arrest fol-
lowed by cardiopulmonary bypass–assisted reperfusion. Results
indicated that reperfusion with levosimendan administration pro-
duced a better clearance of lactate than both epinephrine and con-
trol. Moreover, lactate after epinephrine infusion was even higher
than control, suggesting a noncomplete reperfusion of some region
of the body because of the vasoconstrictive effect of epinephrine.
Dr Kirshbom. So your pump flows were comparable between
groups?
Dr Rungatscher. Yes.ery c January 2012
